Literature DB >> 17178797

Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.

M Simitsopoulou1, E Roilides, C Likartsis, J Ioannidis, A Orfanou, F Paliogianni, T J Walsh.   

Abstract

We assessed the effect of voriconazole (VRC) on the expression and release of selected cytokines and chemokines in the THP-1 human monocytic cell line in response to Aspergillus fumigatus hyphal fragments (HF) by cDNA microarray analysis, reverse transcriptase (RT) PCR, and enzyme-linked immunosorbent assay. Stimulation of THP-1 cells by HF alone caused a significant up-regulation of CCL4 (MIP1B) and CCL16, while CCL2 (MCP1) was down-regulated. By comparison, in the presence of VRC, a large number of genes such as CCL3 (MIP1A), CCL4 (MIP1B), CCL5 (RANTES), CCL7 (MCP3), CCL11 (EOTAXIN), CCL15 (MIP1Delta), CXCL6, and CXCL13 were strongly up-regulated in THP-1 cells challenged by HF, whereas CCL20 (MIP3A) and CCL21 (MIP2) were down-regulated. Among five genes differentially expressed in THP-1 cells, IL12A, IL12B, and IL-16 were down-regulated whereas IL-11 and TGFB1 were significantly up-regulated in the presence of VRC. The inflammation-related genes IFNgamma, IL1R1, and TNFA were also up-regulated in THP-1 cells exposed to HF only in the presence of VRC. RT-PCR of four selected genes validated the results of microarrays. The release of interleukin 1beta (IL-1beta) and IL-12 was significantly increased from monocytes stimulated either by HF alone (P < 0.05) or in the presence of VRC (P < 0.01 and P < 0.05, respectively). In contrast, tumor necrosis factor alpha release from monocytes was enhanced only in the presence of VRC (P < 0.01). The chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta were decreased under both conditions (P < 0.01). These results demonstrate that in the presence of VRC, HF induces a more pronounced profile of gene expression in THP-1 cells than HF alone, potentially leading to more-efficient host resistance to A. fumigatus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178797      PMCID: PMC1803127          DOI: 10.1128/AAC.01095-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

1.  Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.

Authors:  J E Wang; A Warris; E A Ellingsen; P F Jørgensen; T H Flo; T Espevik; R Solberg; P E Verweij; A O Aasen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi.

Authors:  Adilia Warris; Mihai G Netea; Paul E Verweij; Peter Gaustad; Bart-Jan Kullberg; Corry M R Weemaes; Tore G Abrahamsen
Journal:  Med Mycol       Date:  2005-11       Impact factor: 4.076

Review 3.  Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

Authors:  Joel W Alderson; Thomas G Van Dinter; Michael J Opatowsky; Elizabeth C Burton
Journal:  MedGenMed       Date:  2005-09-21

4.  Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression.

Authors:  Katherine S Barker; Teresa Liu; P David Rogers
Journal:  J Infect Dis       Date:  2005-07-20       Impact factor: 5.226

5.  Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.

Authors:  Lawrence H Bopp; Aldona L Baltch; William J Ritz; Phyllis B Michelsen; Raymond P Smith
Journal:  J Med Microbiol       Date:  2006-07       Impact factor: 2.472

6.  Antifungal type 1 responses are upregulated in IL-10-deficient mice.

Authors:  G Del Sero; A Mencacci; E Cenci; C F d'Ostiani; C Montagnoli; A Bacci; P Mosci; M Kopf; L Romani
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

Review 7.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

8.  Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes.

Authors:  George Lagoumintzis; Myrto Christofidou; George Dimitracopoulos; Fotini Paliogianni
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT).

Authors:  T Meshulam; S M Levitz; L Christin; R D Diamond
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

10.  Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display.

Authors:  Tobias M Hohl; Heather L Van Epps; Amariliz Rivera; Laura A Morgan; Patrick L Chen; Marta Feldmesser; Eric G Pamer
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

View more
  13 in total

Review 1.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 2.  Severe asthma with fungal sensitization.

Authors:  Ritesh Agarwal
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

3.  Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.

Authors:  Pietro Lo Giudice; Silvia Campo; Rita De Santis; Giovanni Salvatori
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

4.  Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function.

Authors:  Emily E Rosowski; Jiaye He; Jan Huisken; Nancy P Keller; Anna Huttenlocher
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

5.  Gene expression profiling and network analysis of peripheral blood monocytes in a chronic model of allergic asthma.

Authors:  Glenn P Dorsam; Scott A Hoselton; Ashley R Sandy; Amali E Samarasinghe; Emilie E Vomhof-Dekrey; Sheri T Dorsam; Jane M Schuh
Journal:  Microbiol Immunol       Date:  2010-09       Impact factor: 1.955

6.  Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.

Authors:  Aspasia Katragkou; Michael J Kruhlak; Maria Simitsopoulou; Athanasios Chatzimoschou; Anna Taparkou; Catherine J Cotten; Fotini Paliogianni; Eudoxia Diza-Mataftsi; Chaido Tsantali; Thomas J Walsh; Emmanuel Roilides
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

7.  Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase.

Authors:  Najwane Saïd-Sadier; Eduardo Padilla; Gordon Langsley; David M Ojcius
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  Aspergillus fumigatus conidial melanin modulates host cytokine response.

Authors:  Louis Y A Chai; Mihai G Netea; Janyce Sugui; Alieke G Vonk; Wendy W J van de Sande; Adilia Warris; Kyung J Kwon-Chung; Bart Jan Kullberg
Journal:  Immunobiology       Date:  2009-11-25       Impact factor: 3.144

9.  Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors.

Authors:  Maria Simitsopoulou; Emmanuel Roilides; Fotini Paliogianni; Christodoulos Likartsis; John Ioannidis; Kalliopi Kanellou; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

10.  Deciphering the mechanism of action of 089, a compound impairing the fungal cell cycle.

Authors:  Irene Stefanini; Lisa Rizzetto; Damariz Rivero; Silvia Carbonell; Marta Gut; Simon Heath; Ivo G Gut; Andrea Trabocchi; Antonio Guarna; Nagwa Ben Ghazzi; Paul Bowyer; Misha Kapushesky; Duccio Cavalieri
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.